BioStem Technologies, Inc. (BSEM)
OTCMKTS: BSEM · Delayed Price · USD
7.81
-0.14 (-1.76%)
May 31, 2024, 3:41 PM EDT - Market closed
BioStem Technologies Market Cap
BioStem Technologies has a market cap or net worth of $126.73 million as of May 31, 2024. Its market cap has increased by 377.90% in one year.
Market Cap
126.73M
Enterprise Value
130.45M
1-Year Change
377.90%
Ranking
n/a
Category
Stock Price
$7.81
Market Cap Chart
Since June 3, 2019, BioStem Technologies's market cap has increased from $17.58M to $126.73M, an increase of 620.90%. That is a compound annual growth rate of 48.48%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 31, 2024 | 127.43M | -1.76% |
May 30, 2024 | 129.71M | -5.47% |
May 29, 2024 | 137.22M | 10.51% |
May 28, 2024 | 124.17M | 2.84% |
May 24, 2024 | 120.74M | -0.67% |
May 23, 2024 | 121.56M | -6.29% |
May 22, 2024 | 129.71M | 2.58% |
May 21, 2024 | 126.45M | -4.08% |
May 20, 2024 | 131.83M | -0.74% |
May 17, 2024 | 132.81M | -9.66% |
May 16, 2024 | 147.01M | -7.11% |
May 15, 2024 | 158.27M | 4.64% |
May 14, 2024 | 151.25M | 15.49% |
May 13, 2024 | 130.96M | 9.32% |
May 10, 2024 | 119.80M | -13.90% |
May 9, 2024 | 139.15M | -0.32% |
May 8, 2024 | 139.59M | 0.86% |
May 7, 2024 | 138.40M | 8.64% |
May 6, 2024 | 127.39M | 7.00% |
May 3, 2024 | 119.06M | -11.01% |
May 2, 2024 | 133.79M | -2.71% |
May 1, 2024 | 137.51M | 2.55% |
Apr 30, 2024 | 134.09M | -3.12% |
Apr 29, 2024 | 138.40M | 2.09% |
Apr 26, 2024 | 135.57M | -3.09% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly | 779.66B |
Novo Nordisk | 595.61B |
UnitedHealth Group | 455.93B |
Johnson & Johnson | 353.45B |
Merck & Co. | 317.97B |
AbbVie | 284.73B |
AstraZeneca | 241.90B |
Thermo Fisher | 216.81B |